JND Banner MadMimi
 

Please feel free forward to your colleagues and share the news of our journal

***
JND MadMimi lijn2

NEW ISSUE

Volume 9, Issue 5 / Now Online

Review Article
A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group MeetingOpen Access
Al Shehri, Ali | Al-Asmi, Abdullah | Al Salti, Abdullah Mohammed | Almadani, Abubaker | Hassan, Ali | Bamaga, Ahmed K. | Cupler, Edward J. | Al-Hashel, Jasem | et al.

Short Communication
Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review StudyOpen Access
Elman, Lauren | Youn, Bora | Proud, Crystal M. | Frey, Margaret R. | Ajroud-Driss, Senda | McCormick, M. Eileen | Michelson, David | Cartwright, Michael S. | et al.

RESEARCH ARTICLES
Congenital or Early Developing Neuromuscular Diseases Affecting Feeding, Swallowing and Speech – A Review of the Literature from January 1998 to August 2021Open Access
Sjögreen, Lotta | Bengtsson, Lisa

Newborn Screening for SMA – Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
Blaschek, Astrid | Kölbel, Heike | Schwartz, Oliver | Köhler, Cornelia | Gläser, Dieter | Eggermann, Katja | Hannibal, Iris | Schara-Schmidt, Ulrike | et al.

Slowly Progressive Limb-Girdle Weakness and HyperCKemia – Limb Girdle Muscular Dystrophy or Anti-3-Hydroxy-3-Methylglutaryl-CoA-Reductase-Myopathy?
Hiebeler, Miriam | Franke, Raimo | Ingenerf, Maria | Krause, Sabine | Mohassel, Payam | Pak, Katherine | Mammen, Andrew | Schoser, Benedikt | Bönnemann, Carsten G. | et al.

Expanding the MYOD1 Phenotype: A Case Report of a Patient Diagnosed Whilst Pregnant
Ashton, Catherine | Davis, Mark | Needham, Merrilee | Lamont, Phillipa

Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease
Takahashi, Junichiro | Mori-Yoshimura, Madoka | Ariga, Hajime | Sato, Noriko | Nishino, Ichizo | Takahashi, Yuji

Impact of a 12-week Strength Training Program on Fatigue, Daytime Sleepiness, and Apathy in Men with Myotonic Dystrophy Type 1
Gallais, Benjamin | Roussel, Marie-Pier | Laberge, Luc | Hébert, Luc J. | Duchesne, Elise

Orthopedic Interventions for Foot Deformities in Non-Ambulant People with Duchenne Muscular Dystrophy: A Retrospective Study on Indications, Post-Operative and Long-Term Outcomes
Houwen-van Opstal, Saskia L.S. | Timmer, Amity C. | Ten Ham, A.M. | Hosman, Allard J.F. | Willemsen, Michel A.A.P. | de Groot, Imelda J.M.

Muscle MRI as a Diagnostic Challenge in Emery-Dreifuss Muscular Dystrophy
Pinto, Maria João | Fromes, Yves | Ackermann-Bonan, Isabelle | Leturcq, France | Verebi, Camille | Romero, Norma B. | Stojkovic, Tanya

JND MadMimi lijn2

Most Read JND Articles August 2022

Listing articles published in 2021 & 2022 so you can read the most popular recent content

Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy (Research Article in Vol.9, Iss.4, 2022) – Open Access
Clemens, Paula R. | Rao, Vamshi K. | Connolly, Anne M. | Harper, Amy D. | Mah, Jean K. | McDonald, Craig M. | Smith, Edward C. | Zaidman, Craig M. | et al.

Molecular Mechanisms of Skeletal Muscle Hypertrophy (Review Article in Vol.8, Iss.2, 2021) – Open Access
Schiaffino, Stefano | Reggiani, Carlo | Akimoto, Takayuki | Blaauw, Bert

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy (Review Article in Vol.9, Iss.4, 2022) – Open Access
Biggar, W. Douglas | Skalsky, Andrew | McDonald, Craig M.

Current View of Diagnosing Small Fiber Neuropathy (Review Article in Vol.8, Iss.2, 2021) – Open Access
Raasing, Lisette R.M. | Vogels, Oscar J.M. | Veltkamp, Marcel | van Swol, Christiaan F.P. | Grutters, Jan C.

Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review (Systematic Review in Vol.9, Iss.4, 2022) – Open Access
Audhya, Ivana F. | Cheung, Antoinette | Szabo, Shelagh M. | Flint, Emma | Weihl, Conrad C. | Gooch, Katherine L.

JND MadMimi lijn2

TREAT-NMD News

2022 Conference: Register Now!

Dec 7–9, 2022 | Vancouver, Canada

The TREAT-NMD 7th international conference will take place on Dec 7–9, 2022 in Vancouver, Canada. These dates might seem far away, but it will be here in a flash! The event will be a great opportunity for patients, academics, clinicians, patient registry curators, and industry representatives – indeed all TREAT-NMD stakeholders – to get together to network, learn, and exchange ideas about translational research.

The current program listing can be viewed here.

REGISTRATION DISCOUNT AVAILABLE:
If you register your place this month, you can get 50% discount on conference tickets!

▪ Code: 2022awarenessdays
▪ Deadline: Register by end of September to get 50% discount
Code: 2022awarenessdays
Deadline: Register by end of September to get 50% discount

For further details and updates, go to the TREAT-NMD conference website.

JND MadMimi lijn2

Sign Ups & Social Media

Help Spread the News of JND!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the sign-up link at the bottom of this email or access here.

If you are not yet interacting with JND on social media, why not take the time today to follow us on Twitter and find us on Facebook?

Be part of the discussion!

JND MadMimi lijn2
JND cover klein

Indexed in: PubMed/MEDLINE Scopus

Submit your Paper

As a member of our research community, we would like to invite you to contribute your own articles to the journal. JND offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an affordable open access option (€1250/US$1450). JND is fully compliant with all mandates by major funders, and open access articles are automatically uploaded to PubMed Central. More reasons to publish in JND are outlined on the journal's website!

Submit your manuscript online
View detailed Instructions to Authors
Aims and Scope

JND MadMimi lijn2
***

You are receiving this mailing as you are signed up to receive news from JND.
You can unsubscibe or alter your preferences at any time by clicking the links below
.

 
 
Powered by Mad Mimi®A GoDaddy® company